JP7367950B2 - 抗菌性ポリミキシン誘導体化合物 - Google Patents

抗菌性ポリミキシン誘導体化合物 Download PDF

Info

Publication number
JP7367950B2
JP7367950B2 JP2018516423A JP2018516423A JP7367950B2 JP 7367950 B2 JP7367950 B2 JP 7367950B2 JP 2018516423 A JP2018516423 A JP 2018516423A JP 2018516423 A JP2018516423 A JP 2018516423A JP 7367950 B2 JP7367950 B2 JP 7367950B2
Authority
JP
Japan
Prior art keywords
carboxyl
heteroaryl
trifluoromethyl
amino acid
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2018516423A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018531241A (ja
JP2018531241A6 (ja
JP2018531241A5 (enExample
Inventor
ディー． ロバーツ，ケイド
リー，ジアン
ヴェルコフ，トニー
エル． ネイション，ロジャー
イー． トンプソン，フィリップ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monash University
Original Assignee
Monash University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2015903961A external-priority patent/AU2015903961A0/en
Application filed by Monash University filed Critical Monash University
Publication of JP2018531241A publication Critical patent/JP2018531241A/ja
Publication of JP2018531241A6 publication Critical patent/JP2018531241A6/ja
Publication of JP2018531241A5 publication Critical patent/JP2018531241A5/ja
Priority to JP2021172501A priority Critical patent/JP2022009368A/ja
Application granted granted Critical
Publication of JP7367950B2 publication Critical patent/JP7367950B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/60—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
    • C07K7/62—Polymyxins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2018516423A 2015-09-29 2016-09-29 抗菌性ポリミキシン誘導体化合物 Active JP7367950B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021172501A JP2022009368A (ja) 2015-09-29 2021-10-21 抗菌性ポリミキシン誘導体化合物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2015903961 2015-09-29
AU2015903961A AU2015903961A0 (en) 2015-09-29 Antimicrobial compounds
PCT/AU2016/050915 WO2017054047A1 (en) 2015-09-29 2016-09-29 Antimicrobial polymyxin derivative compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021172501A Division JP2022009368A (ja) 2015-09-29 2021-10-21 抗菌性ポリミキシン誘導体化合物

Publications (4)

Publication Number Publication Date
JP2018531241A JP2018531241A (ja) 2018-10-25
JP2018531241A6 JP2018531241A6 (ja) 2018-12-13
JP2018531241A5 JP2018531241A5 (enExample) 2019-11-07
JP7367950B2 true JP7367950B2 (ja) 2023-10-24

Family

ID=58422486

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018516423A Active JP7367950B2 (ja) 2015-09-29 2016-09-29 抗菌性ポリミキシン誘導体化合物
JP2021172501A Pending JP2022009368A (ja) 2015-09-29 2021-10-21 抗菌性ポリミキシン誘導体化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021172501A Pending JP2022009368A (ja) 2015-09-29 2021-10-21 抗菌性ポリミキシン誘導体化合物

Country Status (7)

Country Link
US (1) US11225505B2 (enExample)
EP (1) EP3356387B1 (enExample)
JP (2) JP7367950B2 (enExample)
CN (1) CN108350034B (enExample)
AU (1) AU2016331658B2 (enExample)
CA (1) CA3000032A1 (enExample)
WO (1) WO2017054047A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2944550C (en) 2014-04-01 2021-05-25 Monash University Polymyxin derivatives as antimicrobial compounds
WO2016083531A1 (en) 2014-11-26 2016-06-02 New Pharma Licence Holdings Limited Compounds
US11225505B2 (en) * 2015-09-29 2022-01-18 Monash University Antimicrobial polymyxin derivative compounds
KR102170659B1 (ko) * 2015-11-25 2020-10-27 오사카 유니버시티 레지스트패턴 형성방법 및 레지스트재료
AU2018359018B2 (en) 2017-11-02 2022-11-24 The University Of Queensland Peptide antibiotics
KR20210054500A (ko) 2018-06-25 2021-05-13 스페로 테라퓨틱스, 인코퍼레이티드 화합물
CN109402008B (zh) * 2018-11-15 2021-09-14 中国农业科学院饲料研究所 一株具有吲哚降解能力的不动杆菌tat1-6a及其应用
JP7045520B2 (ja) 2020-01-02 2022-03-31 上海上薬第一生化薬業有限公司 ポリミキシンｂ成分又はその塩、その製造方法及び使用
CN111072757B (zh) * 2020-01-02 2021-10-15 上海上药第一生化药业有限公司 多黏菌素b组分或其盐及其制备方法和应用
WO2025236916A1 (en) * 2024-05-16 2025-11-20 Brii Biosciences, Inc. Compositions and methods for treating infections

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008505858A (ja) 2004-07-01 2008-02-28 バイオソース・ファーム・インコーポレイテッド ペプチド抗生物質およびその製造方法
US20090215677A1 (en) 2008-02-08 2009-08-27 Martti Sakari Vaara Polymyxin derivatives and uses thereof
WO2012168820A1 (en) 2011-06-08 2012-12-13 Pfizer Inc. Polymyxin derivatives useful as antibacterial agents
WO2015135976A1 (en) 2014-03-11 2015-09-17 New Pharma Licence Holdings Limited Polymyxin derivatives and their use in combination therapy together with different antibiotics

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006045156A1 (en) 2004-10-29 2006-05-04 Monash University Therapy for multi-drug resistant microorganisms
KR100750658B1 (ko) 2005-12-09 2007-08-20 한국생명공학연구원 폴리믹신 생합성 효소 및 이를 코딩하는 유전자 군
US8343912B2 (en) * 2008-12-23 2013-01-01 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
WO2010130007A1 (en) 2009-05-14 2010-11-18 Monash University Antimicrobial compounds
US8415307B1 (en) 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
WO2012051663A1 (en) * 2010-10-21 2012-04-26 Monash University Antimicrobial compounds
EP2780357A1 (en) * 2011-11-18 2014-09-24 Novacta Biosystems Limited Polymyxin derivatives
MX360905B (es) * 2013-01-11 2018-11-21 Xellia Pharmaceuticals Aps Polimixinas, composiciones, metodos de preparacion y metodos de uso.
EP2999711B1 (en) 2013-05-22 2022-06-29 Spero Therapeutics, Inc. Polymyxin derivatives and their use in combination therapy together with different antibiotics
CA2944550C (en) * 2014-04-01 2021-05-25 Monash University Polymyxin derivatives as antimicrobial compounds
US11225505B2 (en) * 2015-09-29 2022-01-18 Monash University Antimicrobial polymyxin derivative compounds

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008505858A (ja) 2004-07-01 2008-02-28 バイオソース・ファーム・インコーポレイテッド ペプチド抗生物質およびその製造方法
US20090215677A1 (en) 2008-02-08 2009-08-27 Martti Sakari Vaara Polymyxin derivatives and uses thereof
WO2012168820A1 (en) 2011-06-08 2012-12-13 Pfizer Inc. Polymyxin derivatives useful as antibacterial agents
WO2015135976A1 (en) 2014-03-11 2015-09-17 New Pharma Licence Holdings Limited Polymyxin derivatives and their use in combination therapy together with different antibiotics

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ＡＣＳ Ｃｈｅｍｉｃａｌ Ｂｉｏｌｏｇｙ，２０１４年，Ｖｏｌ．９，ｐ．１１７２－１１７７
Ｃｈｅｍ．Ｐｈａｒｍ．Ｂｕｌｌ．，２００９年，Ｖｏｌ．５７，Ｎｏ．３，ｐ．２４０－２４４
Ｊｏｕｒｎａｌ ｏｆ Ｍｅｄｉｃｉｎａｌ Ｃｈｅｍｉｓｔｒｙ，２０１３年，Ｖｏｌ．５６，ｐ．５０７９－５０９３

Also Published As

Publication number Publication date
CA3000032A1 (en) 2017-04-06
JP2018531241A (ja) 2018-10-25
AU2016331658B2 (en) 2021-04-01
WO2017054047A1 (en) 2017-04-06
EP3356387A4 (en) 2019-03-13
CN108350034B (zh) 2022-03-11
AU2016331658A1 (en) 2018-04-19
US20180282374A1 (en) 2018-10-04
EP3356387A1 (en) 2018-08-08
EP3356387B1 (en) 2024-06-26
JP2022009368A (ja) 2022-01-14
US11225505B2 (en) 2022-01-18
CN108350034A (zh) 2018-07-31
NZ741027A (en) 2024-05-31

Similar Documents

Publication Publication Date Title
JP7367950B2 (ja) 抗菌性ポリミキシン誘導体化合物
JP7117021B2 (ja) 抗菌性化合物としてのポリミキシン誘導体
JP2018531241A6 (ja) 抗菌性ポリミキシン誘導体化合物
CN103946233A (zh) 多黏菌素衍生物
CA2747995A1 (en) Antibiotic compositions for the treatment of gram negative infections
WO2012051663A1 (en) Antimicrobial compounds
JPH09500103A (ja) シクロヘキサペプチジルアミノアルキルエーテル
ES2332952T3 (es) Nonadepsipeptidos sustituidos en 10 con asparagina.
US12116424B2 (en) Compounds and compositions for modulating Listeria virulence
CA2949328C (en) Low substituted polymyxins and compositions thereof
KR20070083984A (ko) 리소박틴 유도체로서 사용되는 아실화 노나뎁시펩티드
CN101443352A (zh) 从Gaegurin 5合成和制备的抗菌和抗癌多肽的新型类似物
EP4129064A1 (en) Novel antibacterial peptide and use thereof
JP2025525741A (ja) リポオリゴ尿素、医薬組成物、及び薬剤としての使用のためのリポオリゴ尿素
JPH05239095A (ja) １−［４−ヒドロキシ−５−アミノエチルオキシ−ｎ２−（１０，１２−ジメチル−１−オキソテトラデシル）オルニチン−５−（３−ヒドロキシグルタミン）−６−（３−ヒドロキシプロリン）エチノカンジンｂ
CN116375824A (zh) 一种基于mcr-1蛋白的新型抗菌肽及其应用
JP2003505397A (ja) プソイドマイシンのｎ−アシル側鎖アナログ

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20180528

RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20180528

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190925

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190925

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20201013

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210112

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20210622

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211021

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20211021

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20211022

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20211118

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20211124

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20220107

C211 Notice of termination of reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C211

Effective date: 20220118

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20221004

C13 Notice of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: C13

Effective date: 20230418

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230718

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20231004

R150 Certificate of patent or registration of utility model

Ref document number: 7367950

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150